GSK closes sale of two vaccine brands to Bavarian Nordic

This article was originally published here

Under the terms of the transaction agreement, GSK has received an upfront payment of €308m ($345m) and Bavarian Nordic is expected to pay a total of up to

The post GSK closes sale of two vaccine brands to Bavarian Nordic appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply